Mid-day market update: Nasdaq rises over 50 points, Washington prime group shares plunge

Midway through trading Monday, the Dow traded down 0.65% to 34,255.66 while the NASDAQ rose 0.41% to 14,126.79. The S&P also fell, dropping 0.23% to 4,237.53.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 33,462,280 cases with around 599,760 deaths. India confirmed a total of at least 29,510,410 cases and 374,300 deaths, while Brazil reported over 17,412,760 COVID-19 cases with 487,400 deaths. In total, there were at least 176,001,660 cases of COVID-19 worldwide with more than 3,805,010 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Information technology shares climbed 0.5% on Monday. Meanwhile, top gainers in the sector included Canaan Inc. CAN 21.56%, up 26%, and Bit Digital, Inc. BTBT 20.16%, up 27%.

In trading on Monday, materials shares fell 1.3%.

Top Headline

Accenture PLC ACN 0.6% agreed to acquire Aachen, Germany's engineering consulting and services firm, umlaut.

The financial terms of the transaction remain undisclosed

Equities Trading UP

Enochian Biosciences, Inc. ENOB 105.44% shares shot up 107% to $9.11. The FDA has accepted Enochian BioSciences Inc's pre-IND (Investigational New Drug) request for a potential functional cure or treatment of HIV.

Shares of RAPT Therapeutics, Inc. RAPT 112.17% got a boost, shooting 115% to $39.95 as the company announced topline results from its Phase 1b trial of RPT193 as monotherapy for moderate-to-severe atopic dermatitis (AD).

iTeos Therapeutics, Inc. ITOS 37.39% shares were also up, gaining 39% to $27.78. iTeos Therapeutics and GlaxoSmithKline plc have agreed to co-develop and co-commercialize EOS-448, an anti-TIGIT monoclonal antibody.

Equities Trading DOWN

Washington Prime Group Inc. WPG 30.06% shares tumbled 24% to $3.67 after the company filed for Chapter 11 bankruptcy.

Shares of Avenue Therapeutics, Inc. ATXI 30.17% were down 33% to $2.8272 after the company received a second Complete Response Letter from the FDA regarding its marketing application seeking approval for IV tramadol.

Inhibikase Therapeutics, Inc. IKT 18.06% was down, falling 22% to $4.66. Inhibikase Therapeutics filed for offering of up to 8 million shares of common stock.


In commodity news, oil traded up 0.8% to $71.47, while gold traded down 0.7% to $1,865.80.

Silver traded down 0.3% Monday to $28.075 while copper fell 0.1% to $4.5310.

Euro zone

European shares were mostly higher today. The eurozone’s STOXX 600 gained 0.18%, the Spanish Ibex Index rose 0.83% and the German DAX 30 fell 0.13%. Meanwhile, the London’s FTSE 100 gained 0.18%, French CAC 40 climbed 0.24% and Italy’s FTSE MIB rose 0.16%.

Eurozone industrial production increased 0.8% in April versus a revised 0.4% rise in the previous month.


There are no major economic released for Monday.

Benzinga does not provide investment advice. All rights reserved.

Feed news

Latest Forex Analysis

Latest Forex Analysis

Editors’ Picks

EUR/USD refreshes daily high above 1.1850 ahead of EU data

EUR/USD is trading above 1.1850, as it continues to notch higher on Thursday. Dovish Fed downs the US Treasury yields alongside the US dollar. Rebound in Chinese stocks lifts overall market mood, weighing further on the safe-haven dollar. Eurozone data and US GDP in focus.


GBP/USD renews monthly top above 1.3900 on softer USD, Brexit optimism

GBP/USD picks up bids to refresh multi-day high above 1.3900. US dollar tracks Treasury yields to the south amid Fed’s dovish tilt. EU softens legal threat over NI protocol on demand of UK’s Frost. UK scraps quarantine rules for fully vaccinated EU, US travelers.


Gold remains on track to test 200-DMA, US GDP awaited

In the aftermath of the Fed decision, gold price is extending its recent run higher, looking to recapture the critical 200-Daily Moving Average (DMA) at $1821. The market mood has improved amid a rebound in the Chinese stocks.

Gold News

SafeMoon Price Prediction: SAFEMOON contemplates 34% gains

SafeMoon price is experiencing a bottom formation as SAFEMOON approaches a crucial support level twice over the past week. If a bounce from this barrier evolves, it will indicate a double bottom reversal in play. SafeMoon price crashed 20% between July 19 and July 20 to $0.00000273.

Read more

US Q2 GDP Preview: Economy to continue to expand at strong pace

The US Bureau of Economic Analysis (BEA) will release on Thursday, July 29, its first estimate of the annualized Gross Domestic Product (GDP) growth for the second quarter. 

Read more